Week in Review: November 18–22

Chilly mice develop more tumors; gut bacteria aid cancer treatment; two Y chromosome genes sufficient for assisted reproduction; HIV’s “invisibility cloak”

Written byTracy Vence
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

KATHLEEN KOKOLUS AND ELIZABETH REPASKYMice housed in laboratories beneath their natural body temperature of 30°C or 31°C are less able to fend off tumors than animals kept in warmer rooms. Roswell Park Cancer Institute’s Elizabeth Repasky and her colleagues found that compared with their counterparts housed at a comfortable temperature for humans—between 20°C and 26°C—mice injected with tumor cells and kept at 30°C to 31°C showed reduced tumor formation and metastasis, effects mediated by the adaptive immune system. Their work was published this week (November 18) in Proceedings of the National Academy of Sciences.

“It’s one of the things that’s under everybody’s nose, and nobody really thought about it much,” Duke University’s Mark Dewhirst, who was not involved in the work, told The Scientist. “Everybody thought that mice would be fine at room temperature, but nobody ever thought to look.”

WIKIMEDIA, NCIBacteria lining the guts of mice help animals being treated for cancerous tumors by triggering inflammatory and immune system responses. Germ-free or antibiotic-treated mice fared worse than their microbe-laden counterparts, according to two independent studies out this week (November 21) in Science, led by researchers at INSERM in France and the National Cancer Institute.

“Most of the time we think about the gut microbiome shaping the local environment. Now these papers are breaking the glass ceiling and going into extra-intestinal organs . . . and influencing activities of drugs,” said Christian Jobin from the University of Florida, who reviewed both studies but was not involved in either.

“Both ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies